Thirumalaisamy P Velavan

InstitutionUniversity of Tübingen
AddressTübingen
Germany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 17 Covid-19 publications, with a maximum of 3 publications in March 2021
    All Publications
    Bar chart showing 87 publications over 10 distinct years, with a maximum of 12 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Velavan TP, Pallerla SR, Kremsner PG. How to (ab)use a COVID-19 antigen rapid test with soft drinks? Int J Infect Dis. 2021 Oct; 111:28-30. PMID: 34418566.
      Citations:    Fields:    Translation:Humans
    2. Kremsner PG, Mann P, Kroidl A, Leroux-Roels I, Schindler C, Gabor JJ, Schunk M, Leroux-Roels G, Bosch JJ, Fendel R, Kreidenweiss A, Velavan TP, Fotin-Mleczek M, Mueller SO, Quintini G, Schönborn-Kellenberger O, Vahrenhorst D, Verstraeten T, Alves de Mesquita M, Walz L, Wolz OO, Oostvogels L. Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial. Wien Klin Wochenschr. 2021 Sep; 133(17-18):931-941. PMID: 34378087.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    3. Velavan TP, Kuk S, Linh LTK, Lamsfus Calle C, Lalremruata A, Pallerla SR, Kreidenweiss A, Held J, Esen M, Gabor J, Neurohr EM, Shamsrizi P, Fathi A, Biecker E, Berg CP, Ramharter M, Addo MM, Kreuels B, Kremsner PG. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients. Sci Rep. 2021 07 14; 11(1):14471. PMID: 34262116.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    4. Boutin S, Hildebrand D, Boulant S, Kreuter M, Rüter J, Pallerla SR, Velavan TP, Nurjadi D. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs. Cell Mol Life Sci. 2021 Aug; 78(16):5953-5976. PMID: 34223911.
      Citations: 2     Fields:    Translation:HumansAnimalsPHPublic Health
    5. Gabor JJ, Kreidenweiss A, Weber S, Salama M, Sulyok M, Sulyok Z, Koehne E, Esen M, Kreuels B, Shamsrizi P, Biecker E, Mordmüller B, Berg CP, Fusco S, Köhler C, Kubicka S, Leitlein J, Addo M, Ramharter M, Schwab M, Bissinger AL, Velavan TP, Krishna S, Kremsner PG. A call to caution when hydroxychloroquine is given to elderly patients with COVID-19. Int J Infect Dis. 2021 May; 106:265-268. PMID: 33848675.
      Citations:    Fields:    Translation:Humans
    6. Velavan TP, Meyer CG, Esen M, Kremsner PG, Ntoumi F. COVID-19 and syndemic challenges in 'Battling the Big Three': HIV, TB and malaria. Int J Infect Dis. 2021 May; 106:29-32. PMID: 33781904.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    7. Ntoumi F, Mfoutou Mapanguy CC, Tomazatos A, Pallerla SR, Linh LTK, Casadei N, Angelov A, Sonnabend M, Peter S, Kremsner PG, Velavan TP. Genomic surveillance of SARS-CoV-2 in the Republic of Congo. Int J Infect Dis. 2021 Apr; 105:735-738. PMID: 33737129.
      Citations: 1     Fields:    Translation:Humans
    8. Song LH, Hoan NX, Bang MH, Kremsner PG, Velavan TP. Viral and serological testing of SARS-CoV-2 among health care workers and patients in Vietnam. Lancet Reg Health West Pac. 2021 Mar; 8:100113. PMID: 33681829.
      Citations: 2     
    9. Velavan TP, Kieu Linh LT, Kreidenweiss A, Gabor J, Krishna S, Kremsner PG. Longitudinal Monitoring of Lactate in Hospitalized and Ambulatory COVID-19 Patients. Am J Trop Med Hyg. 2021 Jan 11; 104(3):1041-1044. PMID: 33432902.
      Citations: 3     Fields:    
    10. Velavan TP, Meyer CG. COVID-19: A PCR-defined pandemic. Int J Infect Dis. 2021 02; 103:278-279. PMID: 33271291.
      Citations: 7     Fields:    
    11. Velavan TP, Meyer CG. Reply to: Asymptomatic infection by SARS 2 coronavirus: invisible but invincible. Int J Infect Dis. 2021 01; 102:85-86. PMID: 33080400.
      Citations:    Fields:    Translation:HumansCells
    12. Nikolai LA, Meyer CG, Kremsner PG, Velavan TP. Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible. Int J Infect Dis. 2020 Nov; 100:112-116. PMID: 32891737.
      Citations: 67     Fields:    Translation:HumansCellsPHPublic Health
    13. Velavan TP, Pollard AJ, Kremsner PG. Herd immunity and vaccination of children for COVID-19. Int J Infect Dis. 2020 09; 98:14-15. PMID: 32585285.
      Citations: 6     Fields:    
    14. Ntoumi F, Velavan TP. COVID-19 in Africa: between hope and reality. Lancet Infect Dis. 2021 03; 21(3):315. PMID: 32553188.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    15. Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis. 2020 Jun; 95:304-307. PMID: 32344011.
      Citations: 127     Fields:    Translation:HumansCellsPHPublic Health
    16. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020 03; 25(3):278-280. PMID: 32052514.
      Citations: 482     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    17. Kock RA, Karesh WB, Veas F, Velavan TP, Simons D, Mboera LEG, Dar O, Arruda LB, Zumla A. 2019-nCoV in context: lessons learned? Lancet Planet Health. 2020 03; 4(3):e87-e88. PMID: 32035507.
      Citations: 28     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    Velavan's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (253)
    Explore
    _
    Co-Authors (78)
    Explore
    _
    Similar People (60)
    Explore
    _